Innospec Balance Sheet Health
Financial Health criteria checks 6/6
Innospec has a total shareholder equity of $1.1B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.7B and $557.8M respectively. Innospec's EBIT is $176.5M making its interest coverage ratio -76.7. It has cash and short-term investments of $203.7M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -76.7x |
Cash | US$203.70m |
Equity | US$1.15b |
Total liabilities | US$557.80m |
Total assets | US$1.71b |
Recent financial health updates
No updates
Recent updates
Innospec (NASDAQ:IOSP) Has More To Do To Multiply In Value Going Forward
Apr 11Is Innospec Inc. (NASDAQ:IOSP) Potentially Undervalued?
Mar 28Estimating The Fair Value Of Innospec Inc. (NASDAQ:IOSP)
Mar 15Here's Why We Think Innospec (NASDAQ:IOSP) Might Deserve Your Attention Today
Feb 16Innospec (NASDAQ:IOSP) Hasn't Managed To Accelerate Its Returns
Dec 05What Does Innospec Inc.'s (NASDAQ:IOSP) Share Price Indicate?
Oct 14Here's Why We Think Innospec (NASDAQ:IOSP) Is Well Worth Watching
Sep 11Innospec Inc. (NASDAQ:IOSP) Shares Could Be 24% Above Their Intrinsic Value Estimate
Aug 26Should You Investigate Innospec Inc. (NASDAQ:IOSP) At US$98.35?
Jul 07Innospec (NASDAQ:IOSP) Is Looking To Continue Growing Its Returns On Capital
Jun 07Is Innospec Inc. (NASDAQ:IOSP) Trading At A 33% Discount?
May 24Does Innospec (NASDAQ:IOSP) Deserve A Spot On Your Watchlist?
May 09Is It Time To Consider Buying Innospec Inc. (NASDAQ:IOSP)?
Apr 04Investors Will Want Innospec's (NASDAQ:IOSP) Growth In ROCE To Persist
Mar 08Does Innospec (NASDAQ:IOSP) Deserve A Spot On Your Watchlist?
Feb 01A Look At The Intrinsic Value Of Innospec Inc. (NASDAQ:IOSP)
Dec 22Innospec (NASDAQ:IOSP) Is Paying Out A Larger Dividend Than Last Year
Nov 12Return Trends At Innospec (NASDAQ:IOSP) Aren't Appealing
Oct 20Innospec Inc. (NASDAQ:IOSP) Shares Could Be 35% Above Their Intrinsic Value Estimate
Sep 02Here's Why We Think Innospec (NASDAQ:IOSP) Is Well Worth Watching
Aug 19Innospec: A Buy Before The Upcoming Earnings Release
Jul 21Should You Think About Buying Innospec Inc. (NASDAQ:IOSP) Now?
Jul 20Innospec (NASDAQ:IOSP) Has Some Way To Go To Become A Multi-Bagger
Jul 02Innospec (NASDAQ:IOSP) Is Paying Out A Larger Dividend Than Last Year
May 07What Is Innospec Inc.'s (NASDAQ:IOSP) Share Price Doing?
Apr 16Returns At Innospec (NASDAQ:IOSP) Appear To Be Weighed Down
Mar 27Is There Now An Opportunity In Innospec Inc. (NASDAQ:IOSP)?
Jan 06Innospec (NASDAQ:IOSP) Has More To Do To Multiply In Value Going Forward
Dec 19Innospec (NASDAQ:IOSP) Will Pay A Larger Dividend Than Last Year At US$0.59
Nov 06Is It Too Late To Consider Buying Innospec Inc. (NASDAQ:IOSP)?
Aug 29Innospec Inc.'s (NASDAQ:IOSP) Intrinsic Value Is Potentially 23% Below Its Share Price
Aug 11Innospec Inc. 2021 Q1 - Results - Earnings Call Presentation
May 06This Is Why Innospec Inc.'s (NASDAQ:IOSP) CEO Compensation Looks Appropriate
Apr 29Did Innospec Inc. (NASDAQ:IOSP) Insiders Sell Shares?
Mar 15Is Innospec Inc. (NASDAQ:IOSP) A Smart Pick For Income Investors?
Feb 17The Innospec (NASDAQ:IOSP) Share Price Has Gained 89% And Shareholders Are Hoping For More
Feb 02Are Innospec's (NASDAQ:IOSP) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 18Innospec Inc.'s (NASDAQ:IOSP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 03Is There Now An Opportunity In Innospec Inc. (NASDAQ:IOSP)?
Dec 19Financial Position Analysis
Short Term Liabilities: IOSP's short term assets ($885.7M) exceed its short term liabilities ($371.5M).
Long Term Liabilities: IOSP's short term assets ($885.7M) exceed its long term liabilities ($186.3M).
Debt to Equity History and Analysis
Debt Level: IOSP is debt free.
Reducing Debt: IOSP has no debt compared to 5 years ago when its debt to equity ratio was 25.1%.
Debt Coverage: IOSP has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: IOSP has no debt, therefore coverage of interest payments is not a concern.